Matrifen® for Therapy of Severe Chronic Pain®
NCT00699335 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5308
Last updated 2012-05-08
Summary
The aim of the study was to evaluate the efficacy and safety of Matrifen® in patients with severe and chronic pain who could only be sufficiently treated with opioid analgetics (WHO class 3).
Conditions
- Severe Chronic Pain
Interventions
- DRUG
-
Fentanyl transdermal patch. This was an observational study - therefore, the physician decided about dosage according to individual needs
Sponsors & Collaborators
-
Nycomed
lead INDUSTRY
Principal Investigators
-
Dr. Thomas D. Bethke, MD, MBA · Nycomed Deutschland GmbH, 78467 Konstanz, Germany
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-06-30
- Primary Completion
- 2009-07-31
Countries
- Germany
Study Locations
More Related Trials
-
Observational Registry Study of Quality of Life When Treating BTcP With Abstral
NCT01936636 ·Status: COMPLETED
-
Switching From Morphine to Methadone. A Clinical, Pharmacological and Pharmacogenetic Study
NCT00184496 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain
NCT00228605 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Guanfacine on Opioid-induced Hyperalgesia (OIH) and Tolerance
NCT01681264 ·Status: TERMINATED ·Phase: PHASE4
-
Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients
NCT00105287 ·Status: COMPLETED ·Phase: PHASE3
-
Study on Impact of Fentanyl Matrix on Improvement of Pain and Functioning in Spinal Disorder-related Pain
NCT00797017 ·Status: COMPLETED
-
Efficacy and Safety of Fentanyl ETHYPHARM for Breakthrough Pain in Opioid-treated Patients With Cancer
NCT01842893 ·Status: COMPLETED ·Phase: PHASE3
-
The Effectiveness and Tolerability of Fentanyl Matrix in Chronic Non-cancer Pain; Assessment of Patient's Pain Treatment Goal Achievement
NCT01688583 ·Status: COMPLETED
-
Study to Evaluate the Efficacy and Safety of OraVescent Fentanyl Citrate Treatment for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Noncancer-Related Chronic Pain
NCT00343733 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetic Study of Hydrocodone/APAP in Chronic Pain Patients
NCT01517295 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of VER-01 to Opioids in Patients With Chronic Non-specific Low Back Pain
NCT05610813 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients
NCT00842829 ·Status: TERMINATED ·Phase: PHASE4
-
Study on the Development of Opioid Induced Hyperalgesia (OIH) After Exposure to Alfentanil
NCT00991809 ·Status: COMPLETED ·Phase: NA
-
Long-term Opioid Therapy, Misuse and Mortality in Patients With Chronic Non-cancer Pain in Germany
NCT03778450 ·Status: COMPLETED
-
Efficacy and Safety of FITpatch Compared to Standard Opioid Treatment in Cancer Pain (FT-015-IN)
NCT00279344 ·Status: COMPLETED ·Phase: PHASE3
-
Sublingual Methadone for the Management of Cancer-related Procedure Pain in Inpatients
NCT00351637 ·Status: TERMINATED ·Phase: PHASE2
-
Effect of Guanfacine on the Reversal of Opioid-induced Hyperalgesia (OIH)
NCT02192398 ·Status: TERMINATED ·Phase: NA
-
pRedicting the Long-term rEsponse of High Frequency sPinal cOrd sTimulation in Patients With Failed Back Surgery Syndrome.
NCT04500691 ·Status: COMPLETED
-
Efficacy and Safety of Hydromorphone Hydrochloride Extended-Release Compared to Placebo in Subjects With Persistent Pain
NCT00365898 ·Status: TERMINATED ·Phase: PHASE3
-
Safety Study of Oxycodone Hydrochloride and Naltrexone Hydrochloride Extended-Release Capsules in Subjects With Moderate to Severe Chronic Noncancer Pain
NCT01428583 ·Status: COMPLETED ·Phase: PHASE3
-
Investigation of Analgesic and Anti-hyperalgesic Effect of Opioids in Experimental Pain
NCT00647127 ·Status: COMPLETED ·Phase: PHASE3
-
Methadone for 'Adenocarcinopathic' Pain Treatment
NCT05325164 ·Status: WITHDRAWN ·Phase: PHASE3
-
Nasal Fentanyl for Patient Controlled Treatment of Pain in Cancer
NCT01248611 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Long-term Extension Study of BEMA™ Fentanyl
NCT00696137 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Safety of BEMA™ Fentanyl Use for Breakthrough Pain in Cancer Subjects on Chronic Opioid Therapy
NCT00293020 ·Status: COMPLETED ·Phase: PHASE3